254 related articles for article (PubMed ID: 31400636)
21. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
22. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
23. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
Moreaux J; Hose D; Jourdan M; Reme T; Hundemer M; Moos M; Robert N; Moine P; De Vos J; Goldschmidt H; Klein B
Haematologica; 2007 Jun; 92(6):803-11. PubMed ID: 17550853
[TBL] [Abstract][Full Text] [Related]
24. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
25. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
26. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
27. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
28. Features of Isoforms of Human Soluble TACI.
Fichtner ML; Rübsamen H; Smolle M; Schaller J; Feederle R; Bültmann A; Kümpfel T; Schneider P; Thaler FS; Meinl E
J Immunol; 2023 Jul; 211(2):199-208. PubMed ID: 37272840
[TBL] [Abstract][Full Text] [Related]
29. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
30. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.
Yang J; Pospisil R; Ray S; Milton J; Mage RG
PLoS One; 2009 Dec; 4(12):e8494. PubMed ID: 20041151
[TBL] [Abstract][Full Text] [Related]
31. APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.
García-Castro A; Zonca M; Florindo-Pinheiro D; Carvalho-Pinto CE; Cordero A; Gutiérrez del Fernando B; García-Grande A; Mañes S; Hahne M; González-Suárez E; Planelles L
Carcinogenesis; 2015 May; 36(5):574-84. PubMed ID: 25750171
[TBL] [Abstract][Full Text] [Related]
32. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
López De Padilla CM; McNallan KT; Crowson CS; Bilgic H; Bram RJ; Hein MS; Ytterberg SR; Amin S; Peterson EJ; Baechler EC; Reed AM
J Rheumatol; 2013 Mar; 40(3):294-302. PubMed ID: 23322463
[TBL] [Abstract][Full Text] [Related]
33. Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta.
Langat DL; Wheaton DA; Platt JS; Sifers T; Hunt JS
Am J Pathol; 2008 May; 172(5):1303-11. PubMed ID: 18403603
[TBL] [Abstract][Full Text] [Related]
34. TACI regulates IgA production by APRIL in collaboration with HSPG.
Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
[TBL] [Abstract][Full Text] [Related]
35. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
36. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells.
Shen X; Zhu W; Zhang X; Xu G; Ju S
Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696
[TBL] [Abstract][Full Text] [Related]
37. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
Du SW; Jacobs HM; Arkatkar T; Rawlings DJ; Jackson SW
J Immunol; 2018 Dec; 201(11):3258-3268. PubMed ID: 30373855
[TBL] [Abstract][Full Text] [Related]
38. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
39. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
40. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
